By Brad Perriello Medtronic agrees to pay more than $4 million but admits no wrongdoing in settling federal False Claims Act charges that it labelled products manufactured overseas as made in the U.S. Medtronic (NYSE:MDT) agreed to pay $4.4 million but

Related posts:

  1. Medtronic Pays $290k To Settle Wage Discrimination Lawsuit
  2. Medtronic to Pay $4.41 Million to Resolve Allegations that it Unlawfully Sold Medical Devices Manufactured Overseas
  3. Medtronic Agrees to Settle Certain INFUSE® Bone Graft Product Liability Cases
Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone